City Pharmaceuticals And Marketing Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 25 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
About City Pharmaceuticals And Marketing
City Pharmaceuticals And Marketing Private Limited (CPAMPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 October 1999 and has a history of 25 years and four months. Its registered office is in Sundergarh, Odisha, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Purnendu Panda, Rekha Panda, Sukanti Behera, and One other member serve as directors at the Company.
Company Details
-
Location
Sundergarh, Odisha, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U52311OR1999PTC005939
-
Company No.
005939
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
06 Oct 1999
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Cuttack
Industry
Who are the key members and board of directors at City Pharmaceuticals And Marketing?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Purnendu Panda
|
Director | 06-Oct-1999 | Current |
|
Rekha Panda
|
Director | 16-Jan-2022 | Current |
|
Sukanti Behera
|
Director | 17-Jan-2022 | Current |
|
Asish Jena
|
Director | 17-Jan-2022 | Current |
Financial Performance of City Pharmaceuticals And Marketing.
City Pharmaceuticals And Marketing Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of City Pharmaceuticals And Marketing?
In 2017, City Pharmaceuticals And Marketing had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at City Pharmaceuticals And Marketing?
Unlock and access historical data on people associated with City Pharmaceuticals And Marketing, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of City Pharmaceuticals And Marketing, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped City Pharmaceuticals And Marketing's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
